Dyne Therapeutics (DYN) Assets (2019 - 2026)

Dyne Therapeutics' Assets history runs 8 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Assets rose 49.77% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 49.77% YoY), while the FY2025 annual figure was $1.2 billion, up 71.72% from the prior year.
• Assets was $1.1 billion for Q1 2026 at Dyne Therapeutics, down from $1.2 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $1.2 billion in Q4 2025 to a low of $165.1 million in Q4 2023.
• Historically, Assets has averaged $566.9 million across 5 years, with a median of $522.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets plunged 46.11% in 2023, then surged 318.72% in 2024.
• A 5-year view of Assets shows it stood at $306.3 million in 2022, then plunged by 46.11% to $165.1 million in 2023, then soared by 318.72% to $691.2 million in 2024, then jumped by 71.72% to $1.2 billion in 2025, then declined by 9.02% to $1.1 billion in 2026.
• The last three Assets figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $867.1 million (Q3 2025), per Business Quant data.